Cargando…
Serum DNA integrity index as a potential molecular biomarker in endometrial cancer
BACKGROUND: Circulating cell-free DNA (cfDNA) and its integrity index may represent a rapid and noninvasive “liquid biopsy” biomarker, which gives important complementary information for diagnosis, prognosis, and treatment stratification in cancer patients. The aim of our study was to evaluate the p...
Autores principales: | Vizza, Enrico, Corrado, Giacomo, De Angeli, Martina, Carosi, Mariantonia, Mancini, Emanuela, Baiocco, Ermelinda, Chiofalo, Benito, Patrizi, Lodovico, Zampa, Ashanti, Piaggio, Giulia, Cicchillitti, Lucia |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5791183/ https://www.ncbi.nlm.nih.gov/pubmed/29382392 http://dx.doi.org/10.1186/s13046-018-0688-4 |
Ejemplares similares
-
Correction to: Serum DNA integrity index as a potential molecular biomarker in endometrial cancer
por: Vizza, Enrico, et al.
Publicado: (2018) -
Circulating cell-free DNA content as blood based biomarker in endometrial cancer
por: Cicchillitti, Lucia, et al.
Publicado: (2017) -
Robotic single site radical hysterectomy plus pelvic lymphadenectomy in gynecological cancers
por: Vizza, Enrico, et al.
Publicado: (2018) -
Endometrial cancer prognosis correlates with the expression of L1CAM and miR34a biomarkers
por: Corrado, Giacomo, et al.
Publicado: (2018) -
Prognostic Role of the Removed Vaginal Cuff and Its Correlation with L1CAM in Low-Risk Endometrial Adenocarcinoma
por: Vizza, Enrico, et al.
Publicado: (2021)